“Team Talk”: Prescription Stimulants in Sport: Use, Misuse, and Abuse

 

Day One: June 11, 2018

3:30 – 4:00 pm

 

Speaker: David Conant-Norville, MD, F.A.P.A.

Vice President and Clinical Director, Mind Matters, P.C., Child and Adolescent Psychiatry & General Psychiatry, Sports Psychiatry

 

Session Description:

Psycho-Stimulants are medications commonly used effectively to treat psychiatric disorders, primarily ADHD and sleep disorders.  But like many medical treatments, the use of psycho-stimulants can lead to adverse effects, including abuse and addiction.  This session is intended to summarize medical indications for appropriate use of psycho-stimulants and how the medical team should document the medical problems and treatment effects in the medical record.  The session will help the sports medicine team understand the appropriate diagnosis of ADHD and the safe and effective use of stimulants, monitoring for beneficial and adverse effects to treatment and inappropriate use. Clinical examples will be provided and there will be ample time for questions.

 

By the end of the presentation, attendees will be able to:

  • Outline the potential roles of the “team behind the team” in ensuring athlete safety in the appropriate determination of medical need and use of prescription stimulants in sport.
  • Recall current rates of diagnosed need, prescription, and use of prescription stimulants in sport and how these trends impact athlete and team play.
  • Identify common signs and symptoms of misuse and abuse of prescription stimulants among athletes and appropriate actions for protecting athlete health.

 

Speaker Bio:

Dr. Conant-Norville is board certified in general psychiatry and child and adolescent psychiatry. He is president and clinical director of Mind Matters P.C. in Hillsboro, Oregon. Dr Conant-Norville has been practicing psychiatry in many different settings over the past 30 years and is an affiliated assistant professor for the Oregon Health Sciences University Department of Psychiatry. His special interest is sports psychiatry.  He is a member of the World Psychiatric Association Section on Exercise and Sports Psychiatry and the International Society for Sports Psychiatry (ISSP) where he has served on the board of directors since 2002.  Dr Conant-Norville is currently the chair of the Youth Sports committee and Director of Outreach for the ISSP.  For many years, Dr Conant-Norville has served on the Therapeutic Use Exemption Committee for the United States Anti-Doping Agency and the PGA Tour anti-doping program, specializing in reviewing requests of therapeutic use exemptions for banned psychiatric medications, primarily psychostimulants.  Among Dr Conant-Norville’s professional goals are improving youth sports for young athletes by increasing mental wellness skills and using sport as a therapeutic modality to overcome psychiatric illness.